Clinical Trial Update: Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating colesevelam for impaired fasting glucose in patients on niacin therapy for dyslipidemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperglycemia
• Hyperlipidemia

Drugs mentioned

• Colesevelam (colesevelam)

Snippet

Sponsor: Radiant Research | Conditions: Dyslipidemia, Hyperlipidemia | Phase 4 | Status: COMPLETED